Loading chat...
MI SB0623
Bill
Status
10/26/2023
Primary Sponsor
Michele Hoitenga
Click for details
AI Summary
-
Allows licensed prescribers in Michigan to issue prescriptions for off-label drug use after obtaining informed consent from the patient for the treatment regimen
-
Eliminates requirements that prescribers obtain test results before issuing off-label prescriptions for home or outpatient use, that patients have a positive disease screen, or that patients have been exposed to a disease before prophylactic use
-
Permits pharmacies and pharmacists to dispense prescriptions for off-label drug use issued under this section
-
Provides liability protection for prescribers and pharmacists from civil lawsuits and administrative sanctions for off-label prescribing or dispensing, except in cases of gross negligence as defined in MCL 691.1407
-
Defines "off-label use" as any indication other than those stated in the drug's labeling as approved by the United States Food and Drug Administration
Legislative Description
Health: pharmaceuticals; authority to prescribe off-label prescriptions; provide for. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17773.
Health occupations: physicians
Last Action
Referred To Committee On Government Operations
10/26/2023